Company Filing History:
Years Active: 2023
Title: Innovator Xiujun Zheng: Pioneering Advances in Chimeric Antigen Receptors
Introduction: Xiujun Zheng is a notable inventor based in Jiangsu, China. With a focus on biotechnological innovations, he has developed groundbreaking solutions that enhance the efficacy of cancer therapies. His work is particularly significant in the realm of immunotherapy, specifically concerning chimeric antigen receptors (CARs).
Latest Patents: Zheng holds one patent titled "Chimeric antigen receptor and use thereof." This patent discloses a novel chimeric antigen receptor comprising a signal peptide, an antigen binding domain, a transmembrane region, and an intracellular signal domain. Notably, this invention features a 4-1BB signal peptide and/or a 4-1BB molecular transmembrane region. The patent also details the separation and purification of nucleic acid sequences for various chimeric antigen receptors and the development of CAR-T cells targeting the CD19 malignant tumor antigen. In vital tests against hematological cell lines, the enhanced ability of immune cells to recognize and eliminate tumor cells has been demonstrated.
Career Highlights: Xiujun Zheng is affiliated with Nanjing Legend Biotech Co., Ltd., where he plays an integral role in advancing cancer treatment technologies. His innovative spirit and dedication have contributed to the company's standing in the biotechnology sector. Zheng's research and developments enhance the capabilities of CAR-T therapies, marking significant strides in cancer treatment.
Collaborations: Throughout his career, Zheng has collaborated with esteemed colleagues such as Xiaohu Fan and Qiuchuan Zhuang. These collaborations reflect a shared commitment to advancing biotechnological innovations and improving therapeutic outcomes for patients with challenging malignancies.
Conclusion: Xiujun Zheng's contributions to the field of chimeric antigen receptors underscore his status as a leading inventor in biotechnology. His innovative patent and collaborative efforts are paving the way for more effective cancer treatments, demonstrating the vital role of inventors in the ongoing battle against cancer. As the field of immunotherapy continues to evolve, Zheng's work will undoubtedly remain at the forefront of innovation.